Endorsement For NIH Plan

The recent front-page story in The Scientist titled "Scientists Skeptical Of NIH Strategic Plan" (May 11, 1992) does not fully represent the views of the scientific community. I attended two of the five regional National Institutes of Health strategic plan meetings and did not sense the strong criticism and skepticism that the story indicated. One had to read to the very end of the story to reach the conclusions. I am afraid that not all of the readers saw the statement that "Despite initial

Written byJd Andrade
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

One had to read to the very end of the story to reach the conclusions. I am afraid that not all of the readers saw the statement that "Despite initial skepticism from many sectors, the concept of strategic planning for NIH has been strongly endorsed by the extramural community." That was my perception from the Los Angeles and St. Louis meetings.

Another conclusion was that "The fundamental role of investigator-initiated research in the advancement of health science has been reaffirmed." This, too, is my perception--and it was underscored by the various panels and during the general discussion at both of the meetings.

Of course, there is criticism, and there was concern, but generally the NIH officials, in my opinion, were forthright, open, and genuine in their solicitation of input from the extramural community.

I applaud NIH for its scheduling of five regional meetings and for accommodating everyone who wanted to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies